Entry Point Capital, LLC Ani Pharmaceuticals Inc Transaction History
Entry Point Capital, LLC
- $171 Million
- Q3 2024
A detailed history of Entry Point Capital, LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Entry Point Capital, LLC holds 5,990 shares of ANIP stock, worth $340,890. This represents 0.21% of its overall portfolio holdings.
Number of Shares
5,990
Previous 2,724
119.9%
Holding current value
$340,890
Previous $173 Million
99.79%
% of portfolio
0.21%
Previous 0.25%
Shares
3 transactions
Others Institutions Holding ANIP
# of Institutions
212Shares Held
18.8MCall Options Held
11.7KPut Options Held
10.5K-
Black Rock Inc. New York, NY2.66MShares$151 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.35MShares$76.7 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY716KShares$40.8 Million0.01% of portfolio
-
State Street Corp Boston, MA704KShares$40.1 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX655KShares$37.3 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $992M
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...